Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Felberbaum

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Seminars in Reproductive Medicine|October 27, 2001
The role of gonadotropin-releasing hormone antagonists in in vitro fertilizationK Diedrich, M Ludwig, R E Felberbaum
Archives of Gynecology and Obstetrics|April 14, 2000
Deep vein thrombosis during administration of HMG for ovarian stimulationM Ludwig, R E Felberbaum, K Diedrich
Molecular and Cellular Endocrinology|September 16, 2000
Clinical application of GnRH-antagonistsR E Felberbaum, M Ludwig, K Diedrich
Contraception, Fertilite, Sexualite (1992)|December 22, 1999
[Medical treatment of uterine fibroids with the LHRH antagonist: Cetrorelix]R E Felberbaum, M Ludwig, K Diedrich
Archives of Gynecology and Obstetrics|August 5, 2005
Why do couples refuse or discontinue ART?A A Dawson, K Diedrich, R E Felberbaum
Archives of Gynecology and Obstetrics|March 23, 2000
Ovarian abscess and heterotopic triplet pregnancy: two complications after IVF in one patientM Ludwig, R E Felberbaum, O Bauer, et al.
Reproductive Biomedicine Online|January 23, 2003
Safety aspects of gonadotrophin-releasing hormone antagonists in ovarian stimulation procedures: ovarian hyperstimulation syndrome and health of children bornM Ludwig, A Katalinic, R E Felberbaum, et al.
Reproductive Biomedicine Online|July 2, 2003
Safety and efficacy of a 3 mg dose of the GnRH antagonist cetrorelix in preventing premature LH surges: report of two large multicentre, multinational, phase IIIb clinical experiencesF Olivennes, K Diedrich, R Frydman, et al.
Reproductive Biomedicine Online|January 7, 2003
Preoperative reduction of uterine fibroids in only 16 days by administration of a gonadotrophin-releasing hormone antagonist (Cetrotide)R E Felberbaum, W Küpker, M Krapp, et al.
Reproductive Biomedicine Online|December 10, 2002
Use of GnRH antagonists in the treatment of endometriosisW Küpker, R E Felberbaum, M Krapp, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Seminars in Reproductive Medicine|October 27, 2001
The role of gonadotropin-releasing hormone antagonists in in vitro fertilizationK Diedrich, M Ludwig, R E Felberbaum
Archives of Gynecology and Obstetrics|April 14, 2000
Deep vein thrombosis during administration of HMG for ovarian stimulationM Ludwig, R E Felberbaum, K Diedrich
Molecular and Cellular Endocrinology|September 16, 2000
Clinical application of GnRH-antagonistsR E Felberbaum, M Ludwig, K Diedrich
Contraception, Fertilite, Sexualite (1992)|December 22, 1999
[Medical treatment of uterine fibroids with the LHRH antagonist: Cetrorelix]R E Felberbaum, M Ludwig, K Diedrich
Archives of Gynecology and Obstetrics|August 5, 2005
Why do couples refuse or discontinue ART?A A Dawson, K Diedrich, R E Felberbaum
Archives of Gynecology and Obstetrics|March 23, 2000
Ovarian abscess and heterotopic triplet pregnancy: two complications after IVF in one patientM Ludwig, R E Felberbaum, O Bauer, et al.
Reproductive Biomedicine Online|January 23, 2003
Safety aspects of gonadotrophin-releasing hormone antagonists in ovarian stimulation procedures: ovarian hyperstimulation syndrome and health of children bornM Ludwig, A Katalinic, R E Felberbaum, et al.
Reproductive Biomedicine Online|July 2, 2003
Safety and efficacy of a 3 mg dose of the GnRH antagonist cetrorelix in preventing premature LH surges: report of two large multicentre, multinational, phase IIIb clinical experiencesF Olivennes, K Diedrich, R Frydman, et al.
Reproductive Biomedicine Online|January 7, 2003
Preoperative reduction of uterine fibroids in only 16 days by administration of a gonadotrophin-releasing hormone antagonist (Cetrotide)R E Felberbaum, W Küpker, M Krapp, et al.
Reproductive Biomedicine Online|December 10, 2002
Use of GnRH antagonists in the treatment of endometriosisW Küpker, R E Felberbaum, M Krapp, et al.
Pageof 2